We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Another Co. Surrenders In Seroquel XR Patent Fight

Law360, New York (August 1, 2012, 7:11 PM EDT) -- Intellipharmaceutics Corp. has settled patent infringement claims brought by AstraZeneca Pharmaceuticals LP over plans to market a generic version of anti-psychotic drug Seroquel XR, agreeing Monday to delay the launch of its...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.